Methods for treating Blepharitis, Meibomian Gland Dysfunction and Dry Eye Syndrome include thermal massage, thermal debridement, and thermal expression. Particular embodiments include use of handheld devices that provide the thermal therapy to tissue by contacting a surface heated with thermal energy to a patient's tissue. Thermal energy can be continuously provided during operation. In particular embodiments, a handheld device comprises a base assembly operatively connected to a removeable thermal energy applicator. A wide range of thermal applicators may be connected to the base assembly to provide different treatments, including heat application, debridement, and expression of the treated tissue or gland.

A double eyelid formation tape is formed by applying an adhesive, which is used for attaching a tape-shaped member to an eyelid, to the tape-shaped member, which has a long length and which has elastic contractility when the tape-shaped member is stretched to a predetermined length in a longitudinal direction, and that is used for forming a double eyelid by utilizing the elastic contractility of the tape-shaped member. The tape-shaped member is formed of a multilayer body that includes a first base material layer made of a polyethylene and a second base material layer made of polyurethane. When the tape-shaped member is stretched to the predetermined length, the first base material layer is caused to transition to the plastic zone and is configured to have elastic contractility even in the plastic zone.

An assembly for lifting a lower eyelid can be surgically implanted into a patient. The assembly can include a mounting plate, an eyelid support member, and an elongate shaft that extends between and couples the mounting plate to the eyelid support member. The mounting plate can be coupled to facial bone, such as the zygomatic bone, while the eyelid support member contacts and lifts up an inferior tarsus and the lower eyelid of the patient.

An eyelid implant device adapted for placement under an eyelid includes a body having an upper portion and a lower portion, where the upper portion and the lower portion include an asymmetrical weight distribution, such that the lower portion includes an increased weight distribution relative to the upper portion for facilitating the weighting of the eyelid. A plurality of undulations are located on the outer surface of the trapezoidal shaped body and extend in a direction between opposing parallel bases of the body. The eyelid implant is adapted for placement under the eyelid for weighting the eyelid and facilitating eyelid movement, while the plurality of undulations are adapted to restrict post-operative movement of the eyelid implant device relative to the eyelid by contacting with tissue associated with the eyelid during post-operative healing.

Systems, methods, and devices used to treat eyelids, meibomian glands, ducts, and surrounding tissue are described herein. In some embodiments, an eye treatment device is disclosed, which includes a scleral shield positionable proximate an inner surface of an eyelid, the scleral shield being made of, or coated with, an energy-absorbing material activated by a light energy, and an energy transducer positionable outside of the eyelid, the energy transducer configured to provide light energy at one or more wavelengths, including a first wavelength selected to heat the energy-absorbing material.

A method of nonsurgical orbital fat reduction includes providing an electromagnetic energy system that includes an electromagnetic energy source and a patient interface coupled to the electromagnetic energy source. The patient interface includes an elongate member configured to deliver electromagnetic energy generated by the electromagnetic energy source to tissue of a medical patient. The method also includes inserting at least a distal portion of the elongate member into an orbital fat pad of the medical patient and delivering a sufficient amount of electromagnetic energy from the electromagnetic energy source to the orbital fat pad to cause the orbital fat pad to shrink in volume.

Devices and methods are described for electrolytically, ultrasonically, or both electrolytically and ultrasonically disrupting debris on an eyelid margin. A device includes an eyelid contacting portion having at least a first electrode, a second electrode, and a power supply electrically coupled to at least one of the first and second electrodes. The eyelid contacting portion may optionally have a shelf separating an upper portion from a lower portion with electrodes on the upper and lower portions. The eyelid contacting portion may optionally include at least one channel with electrodes. The device may optionally include an ultrasonic driver. Another device includes an ultrasonic driver but no electrodes. A method contacts debris on an eyelid margin with a first electrode and contacting a surface of an eyelid with a second electrode and supplying electrical energy to one of the first or second electrodes to disrupt the debris. Another method applies ultrasonic energy to the eyelid margin to disrupt debris on the eyelid margin.

In implementations of systems for management of dry eye syndrome, a palpebral fissure width is determined as a distance between a medial canthus and a lateral canthus of closed eyelids. An ideal eyelash length is generated based on the distance. Prostheses having the ideal eyelash length are attached to candidate eyelashes of an upper eyelid of the closed eyelids. The prostheses introduce a turbulence to airflow around a tear film which prevents the tear film from evaporating. Dry eye syndrome is managed by preventing the tear film from evaporating.

In implementations of systems for management of dry eye syndrome, a palpebral fissure width is determined as a distance between a medial canthus and a lateral canthus of closed eyelids. An ideal eyelash length is generated based on the distance. Prostheses having the ideal eyelash length are attached to candidate eyelashes of an upper eyelid of the closed eyelids. The prostheses introduce a turbulence to airflow around a tear film which prevents the tear film from evaporating. Dry eye syndrome is managed by preventing the tear film from evaporating.

The invention relates generally to the field of medical devices and, more specifically, to a handheld device that stimulates the meibomian gland of the eyelid mechanically, and specifically stimulates the meibomian glands of the eyelid to treat Meibomian gland dysfunction, also known as Dry eye and chronic marginal eyelid inflammation.